Siegel CH, Sammaritano LR (2024) Systemic lupus erythematosus: a review. JAMA 331(17):1480–1491

Article  CAS  PubMed  Google Scholar 

Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, Le Chen S, Zhang NZ (2008) Rheumatic diseases in China. Arthritis Res Ther 10(1):R17

Article  PubMed  PubMed Central  Google Scholar 

Baker T, Sharifian H, Newcombe PJ, Gavin PG, Lazarus MN, Ramaswamy M, White WI, Ferrari N, Muthas D, Tummala R, Morand EF, Furie R, Vital EM, Chamberlain C, Platt A, Al-Mossawi H, Brohawn PZ, Csomor E (2024) Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials. Ann Rheum Dis 83(8):1018–1027

Article  CAS  PubMed  Google Scholar 

Mohamed AAA, Hammam N, El Zohri MH, Gheita TA (2019) Cardiac manifestations in systemic lupus erythematosus: clinical correlates of subclinical echocardiographic features. Biomed Res Int 2019:2437105

Article  PubMed  PubMed Central  Google Scholar 

Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60(2):221–225

Article  CAS  PubMed  Google Scholar 

Symmons DP, Gabriel SE (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7(7):399–408

Article  PubMed  Google Scholar 

Gualtierotti R, Biggioggero M, Penatti AE, Meroni PL (2010) Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 10(1):3–7

Article  CAS  PubMed  Google Scholar 

Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54(8):2550–2557

Article  CAS  PubMed  Google Scholar 

Avina-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM (2017) Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study. Arthritis Care Res (Hoboken) 69(6):849–856

Article  PubMed  Google Scholar 

Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR, Party EW, on Systemic Lupus E, (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82(5):299–308

Article  PubMed  Google Scholar 

Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(9):515–532

Article  PubMed  PubMed Central  Google Scholar 

Yen EY, Shaheen M, Woo JMP, Mercer N, Li N, McCurdy DK, Karlamangla A, Singh RR (2017) 46-year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013: a nationwide population-based study. Ann Intern Med 167(11):777–785

Article  PubMed  PubMed Central  Google Scholar 

Moghaddam B, Marozoff S, Li L, Sayre EC, Zubieta JAA (2021) All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 61(1):367–376

Article  PubMed  Google Scholar 

Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D’Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145(5):408–415

Article  CAS  PubMed  Google Scholar 

Kostopoulou M, Nikolopoulos D, Parodis I, Bertsias G (2020) Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention. Curr Vasc Pharmacol 18(6):549–565

Article  CAS  PubMed  Google Scholar 

Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 66(4):608–616

Article  PubMed  Google Scholar 

Aringer M, Brinks R, Dorner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrom K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirjak L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumanovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rua-Figueroa I, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR (2021) European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis 80(6):775–781

Article  CAS  PubMed  Google Scholar 

Yang XW, Tan Y, Yu F, Zhao MH (2012) Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Nephrol Dial Transplant 27(9):3552–3559

Article  CAS  PubMed  Google Scholar 

Ambler WG, Kaplan MJ (2024) Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol 20(4):251–265

Article  CAS  PubMed  Google Scholar 

Peeters MA, Chizzolini C (2011) Cardiovascular risk in autoimmune and inflammatory disorders. Rev Med Suisse 7(291):867–871

PubMed  Google Scholar 

McMahon M, Hahn BH, Skaggs BJ (2011) Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. Expert Rev Clin Immunol 7(2):227–241

Article  PubMed  PubMed Central  Google Scholar 

Mok CC, Mak A, Chu WP, To CH, Wong SN (2005) Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore) 84(4):218–224

Article  PubMed  Google Scholar 

Rahman P, Urowitz MB, Gladman DD, Bruce IN, Genest J Jr (1999) Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 26(11):2363–2368

CAS  PubMed  Google Scholar 

Takeda I, Iwadate H, Sugisaki K, Takahashi A, Nogae S, Kanno T, Kasukawa R (2005) Anti-ribosomal P antibodies are associated with nephritis, vascular thrombosis and lymphocytopenia in patients with systemic lupus erythematosus. Fukushima J Med Sci 51(1):11–18

Article  CAS  PubMed  Google Scholar 

Arinuma Y, Kikuchi H, Hirohata S (2019) Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease. Mod Rheumatol 29(4):612–618

Article  CAS  PubMed  Google Scholar 

Hinojosa-Azaola A, Romero-Diaz J, Vargas-Ruiz AG, Nunez-Alvarez CA, Cicero-Casarrubias A, Ocampo-Torres MC, Sanchez-Guerrero J (2016) Venous and arterial thrombotic events in systemic lupus erythematosus. J Rheumatol 43(3):576–586

Article  CAS  PubMed  Google Scholar 

Zamora-Medina MDC, Hinojosa-Azaola A, Nunez-Alvarez CA, Vargas-Ruiz AG, Romero-Diaz J (2019) Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study. Clin Rheumatol 38(3):885–893

Article  PubMed  Google Scholar 

Su J, Hua X, Vikstrom M, Leander K, Gigante B, Hellenius ML, de Faire U, Frostegard J (2013) Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study. BMC Cardiovasc Disord 13:1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J (1999) Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 131(8):573–577

Article  CAS  PubMed  Google Scholar